Li H - Search Results

1

[Disparities of EGFR mutations between Biopsy and Rebiopsy in Non-small Cell Lung Cancer Patients].

Li H, Yan S, Liu X, Liu Y, Ma L, Wang Y, Liu Y, Cheng Y. Li H, et al. Zhongguo Fei Ai Za Zhi. 2018 Nov 20;21(11):821-827. doi: 10.3779/j.issn.1009-3419.2018.11.03. Zhongguo Fei Ai Za Zhi. 2018. PMID: 30454543 Free PMC article. Chinese.

2

[Advanced research on T790M mutation in non-small cell lung cancer].

Li H, Zhang S, Cheng Y. Li H, et al. Zhongguo Fei Ai Za Zhi. 2013 Jun;16(6):314-20. doi: 10.3779/j.issn.1009-3419.2013.06.08. Zhongguo Fei Ai Za Zhi. 2013. PMID: 23769347 Free PMC article. Review. Chinese.

3

[Advances of immunotherapy in small cell lung cancer].

Liu J, Zhang S, Li H, Cheng Y. Liu J, et al. Among authors: li h. Zhongguo Fei Ai Za Zhi. 2014 Jun 20;17(6):474-80. doi: 10.3779/j.issn.1009-3419.2014.06.07. Zhongguo Fei Ai Za Zhi. 2014. PMID: 24949688 Free PMC article. Review. Chinese.

4

[Identification and clinical significance of myeloid-derived suppressor cells in peripheral blood of small-cell lung cancer patients].

Cheng Y, Li H, Zhao D, Han Q, Liu Y, Liu X, Ma L, Liu J. Cheng Y, et al. Among authors: li h. Zhonghua Zhong Liu Za Zhi. 2014 Aug;36(8):592-6. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25430025 Chinese.

5

Circulating tumor cell counts/change for outcome prediction in patients with extensive-stage small-cell lung cancer.

Cheng Y, Liu XQ, Fan Y, Liu YP, Liu Y, Liu Y, Ma LX, Liu XH, Li H, Bao HZ, Liu JJ, Zhang S, Wu CJ. Cheng Y, et al. Among authors: li h. Future Oncol. 2016 Mar;12(6):789-99. doi: 10.2217/fon.15.346. Epub 2016 Feb 3. Future Oncol. 2016. PMID: 26838372 Clinical Trial.

6

[Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer].

Li H, Liu Y, Liu Y, Liu J, Zhao D, Wang Y, Cheng Y. Li H, et al. Zhongguo Fei Ai Za Zhi. 2017 Nov 20;20(11):755-760. doi: 10.3779/j.issn.1009-3419.2017.11.06. Zhongguo Fei Ai Za Zhi. 2017. PMID: 29167005 Free PMC article. Chinese.

7

[Advances on Recognizing and Managing Tumor Heterogeneity].

Zhong R, Li H, Zhang S, Liu J, Cheng Y. Zhong R, et al. Among authors: li h. Zhongguo Fei Ai Za Zhi. 2018 Sep 20;21(9):712-718. doi: 10.3779/j.issn.1009-3419.2018.09.11. Zhongguo Fei Ai Za Zhi. 2018. PMID: 30201072 Free PMC article. Review. Chinese.

8

Somatic mutation of LRP1B is associated with tumor mutational burden in patients with lung cancer.

Lan S, Li H, Liu Y, Ma L, Liu X, Liu Y, Yan S, Cheng Y. Lan S, et al. Among authors: li h. Lung Cancer. 2019 Jun;132:154-156. doi: 10.1016/j.lungcan.2019.04.025. Epub 2019 Apr 28. Lung Cancer. 2019. PMID: 31054778 No abstract available.

9

A novel multi-target tyrosine kinase inhibitor anlotinib combined with irinotecan has in-vitro anti-tumor activity against human small-cell lung cancer.

Li H, Liu Y, Liu X, Zhao D, Liu J, Cheng Y. Li H, et al. Anticancer Drugs. 2020 Nov;31(10):1057-1064. doi: 10.1097/CAD.0000000000000969. Anticancer Drugs. 2020. PMID: 32694423

10

The Prevalence and Concurrent Pathogenic Mutations of KRAS ^G12C in Northeast Chinese Non-small-cell Lung Cancer Patients.

Liu Y, Li H, Zhu J, Zhang Y, Liu X, Li R, Zhang Q, Cheng Y. Liu Y, et al. Among authors: li h, li r. Cancer Manag Res. 2021 Mar 15;13:2447-2454. doi: 10.2147/CMAR.S282617. eCollection 2021. Cancer Manag Res. 2021. PMID: 33758543 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122,659 results

Search Page

Filters